Treatment Guidelines for Eating Disorders

Initial Assessment and Evaluation

All patients with eating disorders require a coordinated multidisciplinary treatment plan incorporating medical, psychiatric, psychological, and nutritional expertise, with disorder-specific psychotherapy as the cornerstone of treatment, as recommended by the American Psychiatric Association 1, 2
Measure temperature, resting heart rate, blood pressure, orthostatic pulse, and orthostatic blood pressure at initial evaluation, according to the American Psychiatric Association 2
Document height, weight, and BMI (or percent median BMI, BMI percentile, or BMI Z-score for children and adolescents), as suggested by the American Psychiatric Association 2
Assess for physical signs of malnutrition or purging behaviors (e.g., Russell's sign, parotid enlargement, dental erosion), as recommended by the American Psychiatric Association 2
Obtain complete blood count to detect anemia, leukopenia, and other hematologic abnormalities, as suggested by the American Psychiatric Association and other guidelines 2, 3
Order comprehensive metabolic panel including electrolytes (sodium, potassium, chloride, bicarbonate), liver enzymes, and renal function tests (BUN, creatinine) to identify hyponatremia, hypokalemia, hypochloremia, metabolic alkalosis, and hepatic or renal dysfunction, according to the American Psychiatric Association and other guidelines 2, 3

Disorder-Specific Treatment Approaches

Family-based treatment (FBT) is the first-line psychotherapy for adolescents and emerging adults with anorexia nervosa who have an involved caregiver, as recommended by the American Psychiatric Association 1, 2
Adults with anorexia nervosa should receive eating disorder-focused psychotherapy that normalizes eating behaviors, restores weight, and addresses psychological aspects including fear of weight gain and body image disturbance, according to the American Psychiatric Association 1, 2
Set individualized goals for weekly weight gain and target weight for all patients requiring nutritional rehabilitation, as suggested by the American Psychiatric Association 1, 2
Adults with bulimia nervosa should receive eating disorder-focused cognitive-behavioral therapy (CBT) combined with fluoxetine 60 mg daily, prescribed either initially or if minimal response to psychotherapy alone occurs by 6 weeks, as recommended by the American Psychiatric Association 1, 2
Family-based treatment should be offered to adolescents and emerging adults with bulimia nervosa who have an involved caregiver, according to the American Psychiatric Association 1, 2
Patients with binge-eating disorder should receive eating disorder-focused cognitive-behavioral therapy or interpersonal therapy, delivered in either individual or group formats, as suggested by the American Psychiatric Association 1, 2
For adults who prefer medication or have not responded to psychotherapy alone, prescribe either an antidepressant or lisdexamfetamine, according to the American Psychiatric Association 1, 2
Monitor QTc intervals in patients with restrictive eating or severe purging, who require ongoing cardiac monitoring due to risk of sudden cardiac death, as recommended by the American Psychiatric Association 1, 2
Perform electrocardiogram in all patients with restrictive eating disorders, severe purging behaviors, or those taking QTc-prolonging medications, as suggested by the American Psychiatric Association 1, 2

Laboratory Testing for Anorexia Nervosa

Essential Initial Laboratory Tests

Obtain thyroid function tests, such as TSH and free T4, in patients with oligomenorrhea or amenorrhea, as recommended by the British Journal of Sports Medicine 4
Consider hormonal workup to assess for hypothyroidism, hypercorticism, and hypogonadotropic hypogonadism, according to the American family physician 5

Additional Testing Based on Clinical Presentation

Measure 25-hydroxyvitamin D levels if low bone mineral density or bone stress injury is suspected, as suggested by the British Journal of Sports Medicine 4
Consider DXA scan for patients with prolonged amenorrhea due to long-term risk of osteopenia and osteoporosis, as recommended by the American family physician 5
Check vitamin B12 and folate levels, particularly in patients with small bowel involvement, as advised by the Journal of Crohn's and Colitis 6

Important Clinical Caveats

Normal laboratory values do not exclude serious illness or medical instability, with approximately 60% of anorexia nervosa patients showing normal values on routine testing even with severe malnutrition, as noted by the American family physician 5

Medical Optimization Requirements Before Eating Disorder Program Admission

Immediate Medical Stabilization Criteria

Patients with severe eating disorder complications must be medically stabilized in an acute care hospital setting before transfer to a specialized eating disorder program, as they meet criteria for life-threatening medical instability, according to the American Academy of Family Physicians 7

Critical Medical Complications Requiring Hospital Treatment

Initiate slow, cautious refeeding with phosphorus supplementation to prevent refeeding syndrome, which can be fatal in severely malnourished patients, as recommended by the American Academy of Family Physicians 7
Nutrition may need to be provided via nasogastric tube or intravenously if oral intake is insufficient, as stated by the American Academy of Family Physicians 7
Assess for hypothyroidism, hypercortisolism, and hypogonadotropic hypogonadism, which are common in severe malnutrition, according to the American Academy of Family Physicians 7
These hormonal abnormalities typically resolve with nutritional rehabilitation and do not require specific treatment, as noted by the American Academy of Family Physicians 7

Psychiatric Stability

Assess and stabilize suicidality, as eating disorders have among the highest mortality rates of any mental illness, with 25% of anorexia nervosa deaths from suicide, according to the British Journal of Sports Medicine 8

Common Pitfalls to Avoid

Do not attempt rapid nutritional rehabilitation, as this increases the risk of fatal refeeding syndrome in severely malnourished patients, as warned by the American Academy of Family Physicians 7
Do not delay hospitalization based on patient or family denial of illness severity, as eating disorders are life-threatening conditions requiring aggressive early intervention, as emphasized by the British Journal of Sports Medicine and the American Academy of Family Physicians 7, 8

Cardiac Complications in Anorexia Nervosa

Pathophysiology and Clinical Significance

The American College of Cardiology notes that prolonged starvation in anorexia nervosa results in both anatomical and electrical cardiac abnormalities, including cardiac muscle atrophy, sinus bradycardia, and QTc interval prolongation, which are directly related to the patient's presentation 9, 10, 11
The American College of Cardiology recommends that patients with anorexia nervosa be monitored for cardiac complications, as up to one-third of deaths in anorexia nervosa are cardiac-related, with sudden cardiac death being a frequent cause of mortality in this population 9, 10, 11
Low weight, low body mass index, and rapid weight loss are the most important independent predictors of QTc interval prolongation in anorexia nervosa, according to the American College of Cardiology 9, 10, 11

Reversibility with Treatment

The American College of Cardiology states that most cardiac manifestations of anorexia nervosa are completely reversible with appropriate nutritional rehabilitation, including resolution of bradycardia, normalization of QTc intervals, and restoration of cardiac muscle mass 9, 10, 11

Critical Management Considerations

The American Heart Association and the American College of Cardiology suggest that carefully controlled refeeding is essential to reduce the risk of ventricular arrhythmias and sudden cardiac death, as overzealous refeeding can trigger the potentially fatal "refeeding syndrome" 9, 10, 12
The European Society of Cardiology recommends that prolonged, unbalanced, very low-calorie diets be avoided, as they may provoke life-threatening ventricular arrhythmias 10, 12, 13

Referral to Psychiatry for Patients with Eating Disorders

Primary Referral Specialty

The American Psychiatric Association recommends that patients with suspected eating disorders be referred first to psychiatry for a comprehensive psychiatric evaluation and for coordination of a multidisciplinary treatment plan. 14, 15

Role of Psychiatry in Multidisciplinary Coordination

Psychiatrists are responsible for orchestrating the multidisciplinary team—including medical physicians, dietitians, and psychotherapists—to ensure integrated care for eating‑disorder patients. 14

Screening and Assessment of Co‑occurring Conditions

A psychiatric assessment for eating‑disorder patients should systematically screen for common comorbidities such as depression, anxiety, obsessive‑compulsive disorder, and suicidal ideation. 14

Involvement of Trained Psychotherapists

Psychotherapists with expertise in eating‑disorder‑focused therapies should deliver cognitive‑behavioral therapy for bulimia nervosa and binge‑eating disorder, as well as family‑based treatment for adolescents with anorexia nervosa, under the supervision of the coordinating psychiatrist. 14

Pharmacologic Management of Eating Disorders in Emerging Adults

Anorexia Nervosa

No FDA‑approved or guideline‑recommended medication exists for anorexia nervosa; treatment relies on psychotherapy and nutritional rehabilitation. 16
Family‑based treatment is the first‑line psychosocial intervention when a caregiver is available, aiming to restore weight and normalize eating patterns. 17
For individuals living independently, eating‑disorder‑focused psychotherapy is the primary treatment modality, targeting fear of weight gain and body‑image disturbance. 17

Bulimia Nervosa

The American Psychiatric Association recommends combining eating‑disorder‑focused cognitive‑behavioral therapy (CBT) with fluoxetine 60 mg daily; fluoxetine may be started initially or added if there is minimal response to psychotherapy after 6 weeks. 18
The therapeutic fluoxetine dose for bulimia nervosa is 60 mg daily, which is higher than the typical antidepressant dosing range. 18
In emerging adults with an involved caregiver, family‑based treatment can be considered as an alternative psychotherapy approach. 18

Binge‑Eating Disorder

Adults with binge‑eating disorder should receive CBT or interpersonal therapy; when medication is preferred or psychotherapy alone is insufficient, treatment may include an antidepressant (e.g., fluoxetine) or lisdexamfetamine. 19
Bupropion is contraindicated in binge‑eating disorder (and bulimia nervosa) because of an elevated seizure risk. 20

Pre‑Medication Medical Assessment

A complete blood count and comprehensive metabolic panel (including electrolytes, liver enzymes, and renal function) are required to detect abnormalities such as hypokalemia or hyponatremia before initiating any medication. 17
An electrocardiogram should be obtained in all patients with restrictive eating or severe purging behaviors to evaluate QTc interval and cardiac risk. 17
Vital signs, including orthostatic pulse and blood pressure, must be recorded to identify cardiovascular instability. 17
Height, weight, and body‑mass index should be documented to guide dosing and monitor nutritional status. 17

Psychiatric Comorbidity Screening

Systematic screening for depression, anxiety, obsessive‑compulsive disorder, and suicidality is essential at every visit; suicide accounts for approximately 25 % of deaths in anorexia nervosa. 18
Assessment for substance‑use disorders should be performed, as these conditions influence medication selection and safety. 16

Common Pitfalls to Avoid

Appetite suppressants and weight‑loss agents (e.g., phentermine, orlistat, GLP‑1 agonists) are contraindicated in eating‑disorder patients due to the risk of worsening restriction and medical complications. 21
Bupropion or the naltrexone/bupropion combination must not be prescribed to individuals with bulimia nervosa or binge‑eating disorder because of a markedly increased seizure risk. 20
Medication monotherapy without concurrent psychotherapy is discouraged; psychotherapy remains the foundational treatment for all eating disorders. 19
Delaying referral to psychiatric or multidisciplinary care should be avoided to ensure coordinated medical, psychological, and nutritional management. 18

Treatment Monitoring & Follow‑Up

For bulimia nervosa patients on fluoxetine, treatment response should be reassessed at 6 weeks; if response is minimal, psychotherapy should be optimized or medication dosage adjusted. 18
Serial QTc monitoring is advised for patients with ongoing restrictive eating or severe purging to detect emerging cardiac risk. 16